Skip to main content

STI Testing: What's Old is New

Supported in part by Roche Diagnostics.

Sexually transmitted infections (STIs), including those caused by Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum and HIV are leading causes of morbidity worldwide. Despite advances in the ability to diagnose and manage HIV infection, there has been resurgence in the number of cases of other STIs. In addition, the incidence of antimicrobial resistance among pathogens associated with STIs has increased, which has created significant challenges in the ability to successfully treat infected individuals. This webinar series will provide an overview of the recent advances that have been made in the diagnosis and management of STIs, with a focus on emerging STI threats, including Mycoplasma genitalium and the rise in antimicrobial resistance among STIs. New technologies that have been developed to target STIs will be introduced, and overviews of new and updated diagnostic algorithms will be discussed.

Webinar Topics (All live webinars are scheduled for 2 pm Eastern)
Aug. 18: STI – Why Can’t We Get Rid of Them?

Barbara Van Der Pol, Ph.D., M.P.H.
University of Alabama at Birmingham

Sept. 1: New Kids on the Block: Mycoplasma genitalium and Neisseria meningitidis

Jose Bazan, D.O.
The Ohio State University College of Medicine

Donna Wolk, Ph.D., D(ABMM), MHA
Diagnostic Medicine Institute, Laboratory Medicine, Geisinger


Sept. 8: Current Laboratory Diagnostic and Monitoring Approaches to HIV Infection: An Update

Joseph D. Yao, M.D., D(ABMM)
Mayo Clinic

Sept. 15: What’s New with HPV and Syphilis


Marc Steben, M.D.
School of Public Health, Montréal University

Anthony Tran, Dr.P.H., M.P.H., D(ABMM)
US Food & Drug Administration


Sept. 29: Point-Counterpoint on Vaginitis Laboratory Testing: Conventional vs. Molecular Testing

April Abbott, Ph.D., D(ABMM)
Deaconess Health System

Melanie Yarbrough, Ph.D., D(ABCC), D(ABMM)
Washington University School of Medicine at St. Louis

Each webinar's content is independent and does not build on the previous webinars in the series, so learners can purchase only those that meet their needs.

Audience
  • General laboratory personnel.
  • Laboratory directors.
  • Healthcare providers caring for patients with STIs.
  • Fellows/Residents.
The level of instruction for this series is Intermediate.

Continuing Education (CE) Credit
Each presentation is approved for 1.0 P.A.C.E. ® credit. ASM is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. All presentations are recognized by the California Department of Health and Florida Department of Health and qualify for California and Florida CE credit toward license renewal. CE credits can only be claimed by the purchaser (individual sales only).

Cost
For individuals-
Single webinar – $35 for ASM members/ $47 for ASM supporting members and non-members
Webinar bundle (all five topics) – $161 ASM members/ $216 for ASM supporting members and non-members

The purchase price includes unlimited access to the webinars through August 18, 2022 and continuing education credit for the purchaser.

Not an ASM member? Join now!

For institutions-
An institutional subscription is available for this course for $259 per webinar. Purchase of institutional subscriptions will allow access and CE credit for up to 10 users. Please email Tamara Lake at tlake@asmusa.org to purchase an institutional subscription.

Format
There are five webinars in this series. The webinars' content does not build on the previous webinars in the series. All of the content is independent so learners can purchase only those that meet their needs.

Each webinar will be presented live and the recording of that presentation will be available within 3 business days. 


If you are purchasing all five topics click this “Add to Cart” to get the bundle price. Adding all topics to your cart individually will result in a higher fee.